A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

A new study finds that weight loss drugs Like Ozempic could trigger bone loss. Doctors explain why, and how to protect ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

The median time receiving treatment was 3.9 months. The researchers found that GLP-1 RA use was associated with a lower rate of any hyperkalemia and moderate-to-severe hyperkalemia compared with ...

The study concentrates on the FDA-approved injectable medications semaglutide and liraglutide. A study conducted by the ...

Some people lose more weight on drugs like Ozempic, Wegovy and Saxenda than others, and a new study reveals why that might be.

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

This change is so pronounced that some bariatric surgery programs have closed. This trend is not just about GLP-1 medications, however. It represents a broader transformation in how the country and ...

As a critical care doctor, I have long considered inflammation a necessary evil, the mechanism through which our bodies sound ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...